Resureccion, Jahzara .

HRN: 28-92-83  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/02/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
07/02/2026
07/09/2026
PO
1.8 Ml
Q8
GI Infection
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: